Share Exchange Agreement. On November 12, 2026 , GridAI Technologies Corp. (the “Company”) entered into a Share Exchange Agreement (as amended by the Addendum (as defined below), the “Exchange Agreement”) by and among the Company, Pronghorn Resources, LLC, a Delaware limited liability company (“Pronghorn”), the members of Pronghorn identified therein (collectively, the “Sellers”), and Nicholas D'Onofrio, as representative of the Sellers. Pursuant to the Exchange Agreement, the Sellers will transfer to the Company all of the issued and outstanding membership units of Pronghorn (the “Units”) in exchange for an aggregate of (i) 1,247,887 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), which, together with the 794,110 shares of Common Stock issuable to Sigma9 (as defined below), represent 19.99% of the shares of Common Stock outstanding prior to the closing, and (ii) up to 129,504.23 shares of the Company’s newly designated Series I Convertible Preferred Stock, par value $0.0001 per share (the “Series I Preferred Stock”), including the Escrow Shares and the Milestone Shares (each as defined below), initially convertible into an aggregate of 64,75
|
GridAI Technologies Corp., formerly Entero Therapeutics, Inc., is a technology and life sciences company operating through two principal areas: energy orchestration software and legacy biopharmaceutical development. The company acquired Grid AI Corp. in September 2025, which develops AI-native software platforms to optimize energy infrastructure for artificial intelligence data centers, distributed energy resources, and residential systems. Grid AI Corp. operates the DLS (Dynamic Load Shaping) platform for front-of-meter optimization of battery storage and solar arrays, and the ALICE Home Energy Management System for behind-the-meter device orchestration. The company targets AI data center developers, hyperscalers, and energy infrastructure providers in North America and Australia. Its legacy biopharmaceutical segment focuses on Adrulipase, a recombinant lipase enzyme for the treatment of exocrine pancreatic insufficiency, developed through its subsidiary First Wave Bio, Inc. The company previously operated as First Wave BioPharma, Inc. before changing its name in May 2024. Summarised from the company's own disclosures, fiscal year ended May 2026 |
Industry Software - Application | Homepage grid-ai.com |
| Sector Technology | IR page grid-ai.com/investors.html | |
|
Tags
energy orchestration, ai data centers, battery energy storage, home energy management, distributed energy resources, grid optimization, biopharmaceuticals, pancreatic insufficiency, Grid AI Corp., AMPX UK Holdings, AMPX Limited, DLS, ALICE, Adrulipase, First Wave Bio Inc., ImmunogenX, Mango Power, Nomad Transportable Power Systems
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | $ 27.163M |
| Market cap (USD) | $ 27.163M |
| P/E | -0.74 |
| PEG | — |
| P/BV | 1.77 |
| P/S | 749.29 |
| P/OCF | -3.14 |
| P/FCF | -4.76 |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | -25.6% |
| ROI | -23.7% |
| ROIC | -19.7% |
| Profit margin | -17,634.4% |
| Growth | |
|---|---|
| Revenue growing | — |
| Profits growing | Yes |
| Revenue up 3y | — |
| Revenue up 5y | — |
| Earnings growth 3y (net profit CAGR) | — |
| Quality | |
|---|---|
| Profitable | No |
| Margin expanding | — |
| Buying back stock | Yes |
| Diluting (TTM) | — |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 83 |
| Quality score | -50.0% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 36.251K | — | — | — | — | — | 0 | — | — | — | — |
| Net profit | -6.393M | -18.059M | -15.795M | -14.63M | -58.538M | -32.671M | -15.178M | -13.534M | -11.096M | -14.592M | -5.93M |
| Free cash flow | -5.703M | -9.218M | -12.878M | -22.344M | -32.358M | -11.226M | -14.058M | -10.925M | -7.217M | -4.547M | -4.195M |
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet detail | ||||||||||
| Trade receivables (USD) | 961,038 | 1.1M | 3.17M | 2.64M | 551,489 | 0.00 | 93,014 | — | 0.00 | 29,974 |
| ↳ YoY growth | -10.6% | +14.9% | +187.3% | -16.9% | -79.1% | -100.0% | ||||
| ↳ 5y CAGR | -12.5% | -39.0% | -44.1% | |||||||
| Lease liabilities (USD) | — | — | 0.00 | 83,235 | 76,540 | 389,127 | 280,211 | 214,060 | 140,534 | 135,609 |
| Cash and deposits (USD) | 0.00 | 573,471 | 1.11M | 175,796 | 6.06M | 8.25M | 1.36M | 3.71M | 163,476 | 899,784 |
| Intangible assets (USD) | — | — | — | — | 2.88M | 0.00 | — | — | 338,402 | 21.8M |
| Right-of-use assets (USD) | — | — | 0.00 | 82,386 | 74,238 | 336,197 | 259,261 | 195,440 | 126,753 | — |
| Cash flow detail | ||||||||||
| Operating cash flow (USD) | -4.53M | -7.18M | -10.9M | -14M | -11.2M | -32.3M | -22.3M | -12.4M | -9.22M | -5.7M |
| Purchases of property, plant and equipment (USD) | -12,355 | -32,168 | -55,473 | -24,098 | -4,167 | -69,488 | — | — | — | — |
| Purchases of intangible assets (USD) | — | — | — | — | 0.00 | -10.3M | — | — | — | — |
| Change in receivables (cash effect) (USD) | — | — | — | — | — | — | — | — | — | 7,295 |
| Change in payables (cash effect) (USD) | 805,765 | -233,777 | 741,624 | -420,788 | -750,027 | 1.42M | -1.99M | -165,763 | 1.64M | 464,200 |
| Interest paid (cash effect) (USD) | -1,393 | -4,148 | -4,010 | -8,032 | -105,460 | 0.00 | -15,879 | -22,463 | -36,165 | — |
| Income taxes paid (cash effect) (USD) | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | — | — | — | — |
| Share-based compensation (USD) | 0.00 | 609,369 | 1.44M | 574,335 | 549,425 | 1.37M | 769,124 | 1.04M | 631,555 | 733,950 |
| Operating cash flow before change in receivables (USD) | — | — | — | — | — | — | — | — | — | -5.71M |
| Free cash flow (OCF - PPE - intangibles) (USD) | -4.55M | -7.22M | -10.9M | -14.1M | -11.2M | -42.6M | — | — | — | — |
| Income detail | ||||||||||
| Research and development expense (USD) | 2.5M | 2.4M | 4.99M | 8.68M | 5.89M | 17M | 8.78M | 5.03M | 903,941 | 925,482 |
| ↳ 5y CAGR | +33.3% | +46.8% | +29.7% | +0.2% | -36.4% | -30.9% | ||||
| Total comprehensive income (USD) | -14.7M | -10.6M | -13.7M | -15.3M | -32.8M | -58.6M | -13.4M | -15.8M | — | — |
| Comprehensive income to owners (USD) | -14.7M | -10.6M | -13.7M | -15.3M | -32.8M | -58.6M | -13.4M | -15.8M | — | — |
| Reported | Mar 16, 2018 | May 14, 2018 | May 15, 2019 | May 15, 2020 | Mar 31, 2022 | Mar 31, 2022 | Mar 20, 2023 | Mar 29, 2024 | Aug 21, 2026 | May 1, 2026 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpMaterial events reported to the SEC on Form 8-K or 6-K, newest first. The link opens the filing itself on EDGAR.
On October 26, 2026, GridAI Technologies Corp. (the “Company”) entered into Amendment No. 4 (the “Amendment”), effective as of September 1, 2026, to the CFO Consulting Agreement dated March 6, 2025, by and between the Company and BPC Consulting Ltd. (the “Consultant”), as previously amended by Amendment No. 1 dated September 24, 2025, Amendment No. 2 effective March 17, 2026, and Amendment No. 3 effective June 1, 2026 (as amended, the “Consulting Agreement”), pursuant to which Anna Skowron provides services as Interim Chief Financial Officer of the Company.
Compensation. Effective September 1, 2026, the Consultant will receive a fixed monthly retainer of $27,000, invoiced in two equal installments on the 15th and last day of each month. The Amendment eliminates the provisions of Amendment No. 2 providing for an hourly rate or separate billing for hours worked in excess of 30 hours per week.
Equity Compensation. Subject to the terms of the Company’s equity incentive plan (the “Plan”) and the availability of shares reserved under the Plan, the Company will grant Ms.
As previously disclosed, on July 17, 2026, GridAI Technologies Corp. (the “Company”) loaned $2,000,000 to Pronghorn Resources, LLC, a Delaware limited liability company (“Pronghorn”), evidenced by a Secured Convertible Note (as amended and restated, the “Note”) and secured pursuant to a Security Agreement between the Company and Pronghorn dated July 17, 2026 (as amended, the “Security Agreement”). On September 4, 2026, the Company advanced an additional $964,000 to Pronghorn and, on October 1, 2026, the Company advanced an additional $536,000 to Pronghorn, and in connection with each such advance the Note was amended and restated and the Security Agreement was amended.
On October 22, 2026, the Company advanced an additional $1,500,000 to Pronghorn (the “Fourth Advance”). In connection with the Fourth Advance, Pronghorn issued to the Company a Third Amended and Restated Secured Convertible Note in the principal amount of $5,000,000 (the “Third A&R Note”), reflecting the aggregate of all advances made by the Company to Pronghorn.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
Company History
Name and ticker changes, and re-registrations under a new regulatory id. When a ticker stopped being used is not recorded, so former tickers are undated.
| Date | Change | Detail |
|---|---|---|
| Sep 5, 2025 | Renamed | ENTERO THERAPEUTICS, INC. → GridAI Technologies Corp. |
| May 30, 2024 | Renamed | FIRST WAVE BIOPHARMA, INC. → ENTERO THERAPEUTICS, INC. |
| Sep 21, 2021 | Renamed | AZURRX BIOPHARMA, INC. → FIRST WAVE BIOPHARMA, INC. |
| Nov 3, 2014 | Renamed | BioPharma d'Azur, Inc. → AZURRX BIOPHARMA, INC. |
| — | Former tickers | FWBI |
ETFs Holding GridAI Technologies Corp.
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| DFSU | 0.00% | 2,539 | $ 13.761K | Nov 12, 2026 |